$15.52 (-2.94%)

Volume: 2.939M

Closed: Jan 27, 2023

Hollow Logo Score: -2.381
Catalyst Pharmaceuticals Stock
$15.52 (-2.94%)

Volume: 2.939M

Closed: Jan 27, 2023

Score Hollow Logo -2.381
NASDAQ:CPRX

Catalyst Pharmaceuticals Stock Price (Quote)

$15.52 ( -2.94% ) Friday, 27th Jan 2023

Range Low Price High Price Comment
30 days $13.30 $22.11 Friday, 27th Jan 2023 CPRX stock ended at $15.52. This is 2.94% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 6.47% from a day low at $15.45 to a day high of $16.45.
90 days $13.30 $22.11
52 weeks $5.24 $22.11

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2023-01-27 $16.00 $16.45 $15.45 $15.52 2 938 583
2023-01-26 $16.98 $16.98 $15.87 $15.99 2 905 014
2023-01-25 $15.70 $16.88 $15.53 $16.73 3 762 454
2023-01-24 $14.79 $16.25 $14.71 $16.12 5 906 344
2023-01-23 $18.32 $18.41 $13.30 $14.76 18 418 325
2023-01-20 $20.45 $21.01 $20.31 $20.80 1 915 762
2023-01-19 $20.31 $20.90 $20.24 $20.27 1 331 300
2023-01-18 $20.30 $20.69 $19.71 $20.43 2 259 002
2023-01-17 $21.53 $21.53 $20.05 $20.14 1 820 533
2023-01-13 $20.83 $22.11 $20.75 $21.05 2 756 704
2023-01-12 $19.81 $21.15 $19.48 $20.97 2 713 525
2023-01-11 $19.71 $20.60 $19.15 $19.81 2 236 249
2023-01-10 $19.06 $19.74 $19.04 $19.73 1 795 500
2023-01-09 $20.20 $20.35 $18.92 $19.02 2 859 849
2023-01-06 $19.20 $20.51 $18.95 $19.60 3 142 000
2023-01-05 $18.58 $18.98 $18.27 $18.83 1 685 896
2023-01-04 $18.06 $18.75 $17.90 $18.55 1 698 184
2023-01-03 $18.70 $18.89 $17.94 $18.06 1 898 729
2022-12-30 $18.22 $18.60 $18.01 $18.60 1 209 769
2022-12-29 $18.50 $19.00 $18.12 $18.34 1 613 070
2022-12-28 $18.54 $18.93 $17.94 $18.13 1 520 699
2022-12-27 $19.04 $19.28 $18.47 $18.59 1 633 741
2022-12-23 $19.50 $19.52 $18.80 $19.01 1 379 172
2022-12-22 $19.46 $19.70 $18.63 $19.35 2 455 266
2022-12-21 $18.92 $19.78 $18.20 $19.50 3 260 644
2022-12-20 $16.80 $18.70 $16.76 $18.60 4 076 134
2022-12-19 $16.00 $16.48 $15.51 $16.41 1 831 676
2022-12-16 $16.74 $16.96 $15.58 $16.00 4 301 155
2022-12-15 $17.58 $17.58 $16.56 $16.84 2 427 220
2022-12-14 $17.78 $18.38 $17.65 $17.71 2 344 468
2022-12-13 $17.95 $17.98 $17.01 $17.80 2 603 432
2022-12-12 $16.68 $17.66 $16.49 $17.41 2 918 602
2022-12-09 $16.76 $16.82 $16.37 $16.38 1 133 581
2022-12-08 $17.01 $17.10 $16.62 $16.80 968 962
2022-12-07 $16.39 $16.91 $16.18 $16.82 1 618 522
2022-12-06 $16.95 $17.09 $16.19 $16.46 2 296 470
2022-12-05 $17.37 $17.55 $16.66 $16.98 2 407 212
2022-12-02 $16.56 $17.55 $16.51 $17.27 3 382 384
2022-12-01 $16.90 $16.90 $16.28 $16.63 1 846 879
2022-11-30 $16.61 $16.86 $15.95 $16.77 2 990 502
2022-11-29 $16.52 $16.92 $16.18 $16.27 2 555 097
2022-11-28 $17.07 $18.39 $16.46 $16.49 3 877 527
2022-11-25 $16.93 $17.11 $16.47 $16.97 1 008 798
2022-11-23 $17.45 $17.76 $16.76 $17.03 3 807 446
2022-11-22 $15.77 $17.71 $15.70 $17.51 6 284 585
2022-11-21 $15.61 $15.68 $14.96 $15.55 1 478 916
2022-11-18 $15.50 $16.15 $15.36 $15.65 1 308 046
2022-11-17 $15.03 $15.20 $14.75 $15.20 958 321
2022-11-16 $15.84 $16.03 $15.22 $15.39 1 012 494
2022-11-15 $16.00 $16.19 $15.47 $15.94 1 564 310

Hot Stocks To Watch:

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT